Stocks and Investing Stocks and Investing
Wed, February 22, 2023

Tiago Fauth Reiterated (ABCL) at Buy and Held Target at $34 on, Feb 22nd, 2023


Published on 2024-10-28 01:48:19 - WOPRAI, Tiago Fauth
  Print publication without navigation


Tiago Fauth of Credit Suisse, Reiterated "AbCellera Biologics Inc." (ABCL) at Buy and Held Target at $34 on, Feb 22nd, 2023.

Tiago has made no other calls on ABCL in the last 4 months.



There are 3 other peers that have a rating on ABCL. Out of the 3 peers that are also analyzing ABCL, 0 agree with Tiago's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Tiago


  • Puneet Souda of "SVB Leerink" Maintained at Buy with Decreased Target to $18 on, Friday, January 6th, 2023
  • Andrea Tan of "Goldman Sachs" Initiated at Strong Buy and Held Target at $30 on, Thursday, December 15th, 2022
  • Robyn Karnauskas of "Truist Securities" Initiated at Strong Buy and Held Target at $29 on, Wednesday, November 16th, 2022

Contributing Sources